🇺🇸 FDA
Patent

US 9103826

Methods and biomarkers for the detection of dengue hemorrhagic fever

granted A61PA61P29/00A61P31/12

Quick answer

US patent 9103826 (Methods and biomarkers for the detection of dengue hemorrhagic fever) held by The Board of Regents of the University of Texas System expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P29/00, A61P31/12, A61P7/04